1. Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
2. Combination therapy with saquinavir soft gelatin capsules in children with human immunodeficiency virus infection
3. Nucleoside exposure in the children of Human Immunodeficiency Virus-infected women receiving antiretroviral drugs: absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States cohorts;Maha;J. Acquir. Immune. Defic. Syndr.,2000
4. Hertogs, K., Mellors, J. W., Schel, P. et al. Patterns of cross-resistance among protease inhibitors in 483 Human Immunodeficiency Virus-1 isolates. [Abstract 395]. In 5th Annual Conference on Retroviruses and Opportunistic Infections, Chicago, Interleukin (1998)
5. Yogev, R., Church, J., Flynn, P. M. et al. Pediatric trial of combination therapy including the protease inhibitor amprenavir (Amprenavir). [Abstract 430]. In 6th Conference on Retroviruses and Opportunistic Infections, Chicago, Interleukin (1999)